In morning trade the Volpara Health Technologies Ltd (ASX: VHT) share price has edged lower after announcing that a group of founders and early investors have sold a portion of shares to institutional investors.
At the time of writing the medical technology company’s shares are down 1% to $1.58.
What did Volpara announce?
According to the release, last week Volpara conducted a series of investor roadshows across Australia and received an unsolicited approach from a broker on behalf of several international and domestic institutions that wished to purchase shares but were unable to build a suitable position on market.
The company’s CEO, Dr Ralph Highnam, explained: “We’ve been on the radar of many of the big domestic and international institutions since the capital raise early this year, but not all of those parties were able to participate in the raise due to demand. Upon receiving the approach to cross the parcel of shares, the Board considered the offer and agreed that it would be beneficial for the Company and its shareholders to strengthen its institutional shareholder base and increase the proportion of stock held in free float.”
The release advises that the block trade involved 6.1 million shares, which equates to approximately 2.8% of Volpara’s issued capital. The various parties sold approximately 12% of their respective holdings, reducing their combined holdings to approximately 23% of the total issued capital.
The block trade took place on September 5 at $1.60 per share, which was a discount of ~3.5% to the closing price on that day.
Chairman Paul Reid commented: “These Directors, founders, and early investors have shown their commitment to the Company over the past 10 years. I’m pleased that this orderly transfer has been facilitated to allow more institutional shareholders to join the register, and allow the Directors, founders, and early investors to realise some of their longheld investment in Volpara. These individuals remain totally committed to the business and its work in the early detection and, ultimately, prevention of breast cancer. Furthermore, the Directors advise they have no intention to sell further shares in the foreseeable future.”
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of VOLPARA FPO NZ. The Motley Fool Australia has recommended VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.